Franklin Resources Inc Clearside Biomedical, Inc. Transaction History

Franklin Resources Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.08 - $1.83 $730 - $1,237	676 Added 0.89%	76,717 $87,000
Q2 2022 Aug 11, 2022	SELL	$1.3 - $2.49 $46,243 - $88,574	-35,572 Reduced 31.87%	76,041 $112,000
Q4 2021 Feb 11, 2022	SELL	$2.72 - $5.72 $780 - $1,641	-287 Reduced 0.26%	111,613 $307,000
Q3 2021 Nov 12, 2021	BUY	$4.83 - $7.2 $540,477 - $805,680	111,900 New	111,900 $671,000

12.2M

54.7K

50.7K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $61.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

Stay updated on Franklin Resources Inc with notifications on news.